Form EFFECT AMICUS THERAPEUTICS,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 29, 2026 |
| Accession Number: | 0001140361-26-016985 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hesai Group to Report Third Quarter 2026 Financial Results on Tuesday, November 10, 2026
- Varnish Software Powers SecureEdge, Continent 8's CDN for the Global iGaming Industry
- Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 19 10 2026] - (CGWL)
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share